Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

NCT00712933

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site La Plata, Buenos Aires, Argentina
  • GSK Investigational Site Rosario, Santa Fe Province, Argentina
View all 110 locations
View Trial Details
Completed

GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia

NCT01345253

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Hefei, Anhui, China
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Guangzhou, Guangdong, China
View all 47 locations
View Trial Details
Completed

Preventive IVIG Therapy for Congenital Heart Block

NCT00460928

Conditions
Arthritis, Arthritis, Rheumatoid, Autoantibody-Associated Heart Block, +20 more
Locations
  • Saint Barnabas Medical Center Livingston, New Jersey, United States
  • New York University School of Medicine / NYU-Hospital for Joint Diseases New York, United States
View Trial Details
Completed

Monitoring the IMmUological TOXicity of Drugs

NCT03480529

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France
  • Rhumatology department, CHU Strasbourg, Hautepierre hospital Strasbourg, France
View Trial Details

Related conditions